drugset
drugset / Trial / NCT03633487

Study to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release Tablet

NCT03633487 ↗

Phase 1 Completed 24 enrolled Reckitt Benckiser Inc.
NaSingle-groupOpen-labelBasic science

Summary

Characterize and assess PK of guaifenesin in Mucinex® 1200 mg ER Bi-Layer Tablet

Timeline

Start
2011-10-11
Primary completion
2011-10-15
Completion
2011-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Guaifenesin Small molecule 1200 mg —

Indications

No indication recorded.